Companies in
Pharmaceutical Industry

Dr. Pharmandrus GmbH

Research & Development · Eich · Since 2016

The core activity of Dr. Pharmandrus GmbH is the development, manufacture and marketing of dietary supplements, in particular vitamin C products such as VitaScorbin drops, as well as the distribution of over-the-counter pharmaceutical products on the Swiss market.

Dr. Reddy's Laboratories SA

Pharmaceutical Industry · Basel · Since 2007

The company's core activity is the development, manufacture and marketing of pharmaceutical products, including generics, biosimilars, over-the-counter products and innovative medicines for various therapeutic areas such as gastroenterology, cardiology, diabetology, oncology, pain management and dermatology.

Dr. Schweizer Immunocare AG

Pharmaceutical Industry · Neuhausen Am Rheinfall · Since 2015

The core activity of Dr. Schweizer Immunocare AG is the development, manufacture and distribution of dietary supplements, particularly in the area of immune system support.

Drug'On Pharma Switzerland AG

Chemical Industry · Liestal · Since 2009

Drug'On Pharma Switzerland AG is part of the Orofino Pharmaceuticals group and operates a chemical production site manufacturing active pharmaceutical ingredients (APIs) and intermediates. The site comprises four production buildings and provides chemical manufacturing capabilities for APIs and intermediates.

DSM Nutritional Products Holding AG

Pharmaceutical Industry · Kaiseraugst · Since 2004

DXC I. C. AG

Pharmaceutical Industry · Hünenberg · Since 2016

The core activity of DXC I.C. AG includes: International Trading, Product development and production, Project investments in biotechnology, Marketing development for health, wellness and medical products. The company focuses particularly on the development and production of health products based on the combination of natural ingredients and innovative technologies.

DXC RT AG

Research & Development · Aesch Bl · Since 2015

The core activity of DXC RT AG is the development and application of biotechnological solutions, particularly the NovaPhyRT technology, for the cultivation of plant roots in laboratories. The company specializes in the production of root biomass, including Hairy Root, Adventitious Root and Callus and cell suspensions, and supplies these products to customers in the cosmetics and care industry. In addition, DXC RT also offers customized research and development services.

Effectum Medical AG

Pharmaceutical Industry · Olten · Since 2017

Effectum Medical AG provides regulatory and quality‑management services for medical technology companies. Its offerings include ISO 13485‑compliant plug‑and‑play QMS, outsourced legal manufacturer services for MDR/IVDR CE‑marking, on‑demand QA/RA experts, regulatory opinions, and AI/ML compliance support.

EFFIK SA

Pharmaceutical Industry · Nyon · Since 2006

EFFIK SA is a pharmaceutical company specializing in the development, manufacture, and distribution of medicines, medical devices, and dietary supplements. The company's core activities include: * Research and development of new therapies and products, particularly in the fields of gynecology, neurology, hematology, and cardiology * Manufacturing and distribution of medicines, medical devices, and dietary supplements * Development of solutions for specific patient groups, such as women in various life situations (e.g. pregnancy, menopause) * Collaboration with medical experts and physicians to develop innovative solutions and improve patient care The company focuses on developing products tailored to the specific needs of patients and healthcare providers, and values quality, innovation, and patient proximity.

EffRx Pharmaceuticals SA

Pharmaceutical Industry · Freienbach · Since 2009

The core activity of EffRx Pharmaceuticals SA is the development, approval and marketing of medicines for rare and niche diseases in Europe and Switzerland. The company focuses particularly on the late-stage development and market entry of therapeutics for patients with rare diseases such as osteoporosis, adrenal insufficiency, congenital adrenal hyperplasia and Niemann-Pick disease. EffRx works closely with partners to develop and bring new medicines to market, offering accelerated decision-making processes and rapid market entry for its customers.

EHC (EUROPEAN HEALTH CORPORATION) SA

Pharmaceutical Industry · Geneva · Since 2010

EHC (EUROPEAN HEALTH CORPORATION) SA develops and commercializes consumer healthcare and self-care products, including OTC medicines, medical devices and dietary supplements. The company conducts acquisitions, in-/out-licensing, distribution and brand promotion, and partners with distributors and laboratories to bring its products to market.

Eisai Pharma AG

Pharmaceutical Industry · Zurich · Since 2005

Eisai Pharma AG is a research and development-oriented pharmaceutical company specializing in the research, development, and distribution of products in the fields of neurology and oncology. The company's core activity is the development and provision of innovative treatment options for patients with severe illnesses, particularly in the fields of neurology and oncology.

Elanco Tiergesundheit AG

Research & Development · Basel · Since 1997

The core activity of Elanco is the development and manufacture of animal health medicines and products that improve the health, well-being and performance of animals, as well as providing services and solutions for animal health.

Elixan Aromatica GmbH

Pharmaceutical Industry · Gähwil · Since 1995

The core activity of Elixan Aromatica Pharma GmbH is the manufacture and distribution of aromatherapy products, essential oils, phytopharmaceuticals and medicinal products. The company also offers private-label solutions, where it manufactures products for other companies and equips them with the label and packaging of the client.

Elthera AG

Pharmaceutical Industry · Zug · Since 2016

The core activity of Elthera AG is the development of precision medicine oncology solutions, particularly the research and development of L1CAM-based immunotherapies to combat aggressive tumors.

Enable Biotech AG

Pharmaceutical Industry · Zug · Since 2023

The core activity of Enable Biotech is the development and manufacturing of cell and gene therapies (ATMPs) as well as exosome therapies for clinical trials. The company offers Contract Development and Manufacturing Organization (CDMO) services, including process development, clinical manufacturing, quality control, and regulatory support. Enable Biotech focuses on the needs of start-ups and small companies in the field of advanced therapies, providing flexible and cost-effective solutions for the production of cell and gene therapies.

Endogena Therapeutics AG

Pharmaceutical Industry · Zurich · Since 2020

The core activity of Endogena Therapeutics is the development of therapies to repair damaged tissue by activating the body's own regenerative capabilities. To achieve this, the company combines artificial intelligence with years of experience in drug development to identify small molecules that can specifically activate the body's own stem cells. A key focus is on the development of therapies for inherited blindness and other degenerative diseases.

ENWOTEC AG

Technical Consulting & Engineering · St. Gallen · Since 2024

The core activity of ENWOTEC AG is the development and provision of filtration solutions and products for various industries, including water treatment, biotechnology, food and beverage, chemicals, plasmapheresis, cosmetics, flavors and fragrances, as well as cannabis. The company offers a wide range of filtration products, including filter cartridges, functional granulates, functional membranes, depth filter pads, lens modules, activated carbon filter paper, and single-use solutions. In addition, ENWOTEC AG provides consulting services for the optimization of filtration processes.

enzymmanagement ag

Research & Development · Tägerwilen · Since 2007

enzymmanagement ag develops and produces bioactive cosmeceutical and topical treatments targeting benign fatty‑tissue tumors and certain rare diseases such as multiple symmetric lipomatosis and estradiol‑dependent breast cancer. Its developments are based on intracrinological and biochemical principles of local steroid production and metabolism in target tissues.

EpiPharm AG

Pharmaceutical Industry · Binningen · Since 2007

EpiPharm AG is a clinical-stage biotechnology company developing topical treatments and dermato-cosmetic products based on multi-active, plant-derived compositions that include artemisinin derivatives. Its projects address skin disorders such as seborrhoeic keratosis and pigmented lesions, and the company offers co-development and licensing opportunities for its pipeline.

Epithelix Sàrl

Pharmaceutical Industry · Plan-Les-Ouates · Since 2006

Epithelix Sàrl develops and supplies in vitro reconstituted human respiratory tissue models and associated culture media, including MucilAir™, SmallAir™ and AlveolAir™. The company also provides laboratory testing services (CRO), such as viral and bacterial infection assays, inhalation toxicity testing, nasal spray evaluation and mucociliary endpoint analyses.

EQX Healthcare AG

Pharmaceutical Industry · Baar · Since 2024

EQX Healthcare AG produces and sells natural dietary supplements for horses, developing formulations with veterinarians to support digestive health, metabolism, respiratory function and the musculoskeletal system.

EraCal Therapeutics AG

Pharmaceutical Industry · Basel · Since 2018

The core activity of EraCal Therapeutics is the development of solutions to combat obesity (obesity) based on scientific research.

ESC Biotech Swiss AG

Pharmaceutical Industry · Basel · Since 2023

ESC Biotech Swiss AG is a biotechnology and pharmaceutical manufacturing company offering end-to-end CDMO services for cell and gene therapies and vaccines. Services include process development, fill-and-finish, quality and regulatory support, program/project management, modular production suites, laboratories, cryostorage and a proprietary Process Reinforcement Technology (PRT).

Eugenex Biotechnologies GmbH

Research & Development · Tägerwilen · Since 1999

Eugenex Biotechnologies GmbH develops expression cell lines and process solutions for animal component‑free production of biosimilars and novel biopharmaceuticals. The GeneXpress technology platform includes CHOSI host cell lines, protein‑free MAM‑PF media and pMOZ expression plasmids, and the company offers ready‑to‑go biosimilar processes, cell line and process development, gram‑scale protein production (non‑GMP), analytical and cell‑based assays and technology transfer.

Eurofins NSC Schweiz AG

Pharmaceutical Industry · Schönenwerd · Since 2020

EvlaBio AG

Research & Development · Zurich · Since 2022

The core activity of EvlaBio AG is the development of therapeutics, particularly first-in-class therapeutics in the field of cardiovascular and cardio-renal diseases. The focus is on the development of therapeutic monoclonal antibodies (mAb) that target specific target molecules such as FGFR4/FGF23 to treat chronic kidney diseases (CKD).

Evultis SA

Pharmaceutical Industry · Stabio · Since 1978

The core activity of Evultis SA encompasses the development, manufacturing and distribution of products for the healthcare industry, including: active pharmaceutical ingredients (APIs) and intermediates; pharmaceuticals; dietary supplements (nutraceuticals); cosmetics; veterinary medicines; feed and feed additives; and pet food supplements. The company offers these products for human and animal health and invests in research and development to create innovative solutions for the healthcare industry.

Excellgene SA

Research & Development · Monthey · Since 2004

ExcellGene is a Swiss Biologics-CDMO (Contract Development and Manufacturing Organization) specialized in the development and manufacturing of proteins for the pharmaceutical industry. The company's core activity encompasses providing services for the development and manufacturing of biologics, including: cell line development (CHO and HEK cells), genome engineering, cGMP cell banking, process development, ensuring clonality of existing cell lines, and biosimilars. The company supports pharmaceutical companies in the development and manufacturing of proteins for drug development, offering a combination of scientific expertise and technological infrastructure.

Excellness Biotech SA

Medical Technology Industry · Lausanne · Since 2009

Exeltis Suisse SA

Pharmaceutical Industry · Plan-Les-Ouates · Since 2022

The core activity of Exeltis is the development, manufacture and marketing of medicines and health products for women's health, particularly in the areas of contraception, pregnancy and lactation.

Exogems SA

Pharmaceutical Industry · Epalinges · Since 2024

Exopharm AG

Pharmaceutical Industry · Bern · Since 2017

Exopharm AG supplies pharmaceutical products, including branded medicines and generics, and related medical accessories and services to regional distributors. Its services include logistics (including GDP-compliant cold chain), regulatory affairs (pre- and post-marketing and market access) and promotional support.

Extrovis AG

Research & Development · Baar · Since 2016

Extrovis AG is a global Contract Research, Development & Manufacturing Organization (CRDMO) that develops and manufactures complex specialty therapeutics, including sterile antibiotics, oncology and cytotoxic formulations, and female hormone products. The company provides R&D, regulated-market manufacturing (USFDA, EU‑GMP) and supply‑chain and regulatory support across drug substances and finished dosage forms.

FatiAbGen International GmbH

Pharmaceutical Industry · Basel · Since 2024

FatiAbGen International GmbH develops monoclonal antibody–based therapies and antibody–drug conjugates for oncology and immunological disorders. The company maintains a pre-clinical pipeline and engages in research collaborations.

Ferring Pharmaceuticals SA

Pharmaceutical Industry · St-Prex · Since 2007

Ferring Pharmaceuticals SA is a biopharmaceutical company that develops medicines and therapies for gastroenterology, urology and reproductive medicine. The company conducts research, clinical development and maintains a product pipeline.

Ferring International Center SA

Pharmaceutical Industry · St-Prex · Since 2000

Ferring AG

Pharmaceutical Industry · Baar · Since 2007

Ferring AG is a biopharmaceutical company that develops medicines and therapies for gastroenterology, urology and reproductive medicine.

FGK Representative Service AG

Pharmaceutical Industry · Beinwil (Freiamt) · Since 2014

FGK Representative Service AG provides legal sponsor representation for companies that do not have a subsidiary, enabling them to conduct clinical research projects. Services include representation for clinical trials with drugs, clinical investigations with medical devices, support for orphan medicinal products, assistance with marketing authorization procedures and SME‑status matters.

Floratek Pharma SA

Pharmaceutical Industry · Belmont-Sur-Lausanne · Since 2015

The core activity of Floratek Pharma is the discovery and development of new therapeutic active ingredients based on plant ingredients for the treatment of diseases, particularly in the field of cancer and central nervous system diseases. The company uses artificial intelligence and computer-aided models to design and optimize small molecules that specifically influence biological processes, thus offering new treatment options for various diseases.

fondation Innovative Medicines for Tuberculosis (iM4TB)

Pharmaceutical Industry · Lausanne · Since 2014

The core activity of iM4TB is the development of innovative medicines to combat tuberculosis. The company researches and develops new treatment methods and agents to eliminate tuberculosis.

Fondazione Ceschina

Pharmaceutical Industry · Lugano · Since 2013

The core activity of Sanitaria Ceschina & C. (S.p.A.) is the manufacture and distribution of medical products, particularly aseptic and antiseptic medications as well as health equipment.

Fordras SA

Research & Development · Lugano · Since 1983

The company's core activity is the development, production and marketing of natural proteins and enzymes for the food, pharmaceutical and feed industries. The company focuses particularly on the production of highly concentrated, active ingredients for industrial applications, such as lysozymes, and offers solutions for food processing and preservation as well as for the health and nutrition industry.

FormuLAB GmbH

Pharmaceutical Industry · Lütisburg Station · Since 2009

The core activity of FormuLAB GmbH is the development and manufacture of food supplements, cosmetics and pharmaceuticals on a contract basis for pharmacies and drugstores. The company offers comprehensive services, from recipe development and raw material procurement to production, packaging and labeling of the final products.

Fresenius Kabi SwissBioSim GmbH

Pharmaceutical Industry · Eysins · Since 2017

Frutig Grow GmbH

Pharmaceutical Industry · Rothrist · Since 2021

The core activity of Frutig Grow is the cultivation, processing and sale of CBD products, in particular CBD flowers, as well as the performance of cannabinoid analyses.

Future Health Pharma GmbH

Pharmaceutical Industry · Wetzikon Zh 1 · Since 2007

Future Health Pharma GmbH represents European, US and Chinese companies and registers, distributes and markets their medicinal and health-related products in Switzerland and EU countries. The company acts as Marketing Authorisation Holder or establishes affiliates and holds an establishment licence to handle controlled substances and vaccines; its portfolio includes prescription and over-the-counter medicines, medical devices and food supplements.